Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Cytokines | Research article

Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens

Authors: Rajni Upadhyay, Bhavyata Dua, Bhawna Sharma, Mohan Natrajan, Ajai Kumar Jain, Balaji Kithiganahalli Narayanaswamy, Beenu Joshi

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Leprosy is an ideal human disease to study T cell regulation as patients show correlation between cytokine skewed Th1-Th2 responses and clinical forms of the disease. The Role of transcription factors on the modulation of Th1 and Th2 responses by M. leprae antigens has not been adequately studied. In the present study, we studied the effect of M. leprae antigens on transcription factors STAT-4, STAT-6 and CREB and their correlation with Th1/Th2 cell mediated immune responses in leprosy.

Methods

Leprosy patients of both categories of tuberculoid leprosy (BT/TT) and lepromatous leprosy (BL/LL) were selected from the OPD of NJ1L & OMD, (ICMR), Agra and healthy individuals (H) were chosen from the staff and students working in the institute. Peripheral blood mononuclear cells (PBMCs) of the study subjects were stimulated with M. leprae antigens (WCL, MLSA, and PGL-1). Sandwich ELISA was done in the culture supernatants of healthy and leprosy patients to detect IL-4, IL-10 and IFN-γ. Further, expression of IFN-γ and IL-4 and activation of STAT4, STAT6 and CREB transcription factors in CD4+ T cell with or without stimulation of M. leprae antigens was investigated by flow cytometry.

Results

Lepromatous leprosy patients showed significantly lower IFN-γ and higher IL-4 levels in culture supernatant and significantly low expression of IFN-γ and higher expression of IL-4 by CD4+ T cells than healthy individuals with or without antigenic stimulation. Antigenic stimulation significantly increased IL-10 in BL/LL patients but not in BT/TT patients or healthy individuals. PGL-1 stimulation led to significantly higher activation of STAT-6 in BT/TT and BL/LL patients in comparison to healthy individuals. All the three antigens led to activation of CREB in healthy and BT/TT patients but not in BL/LL patients.

Conclusion

Our findings show that M. leprae antigens differentially modulate activation of T cell transcription factors STAT-4/STAT-6 and CREB. These transcription factors are well known to regulate Th1 and Th2 mediated immune response which in turn could play vital role in the clinical manifestations of leprosy. These observations may help to determine how these T cell transcription factors affect the development of immune dysfunction and whether these new pathways have a role in immunomodulation in intracellular diseases like leprosy and TB.
Literature
1.
go back to reference World Health Organisation (WHO). Global leprosy update, 2017: reducing the disease burden due to leprosy. Wkly Epidemiol Rec. 2018;93(35):445–56. World Health Organisation (WHO). Global leprosy update, 2017: reducing the disease burden due to leprosy. Wkly Epidemiol Rec. 2018;93(35):445–56.
2.
go back to reference Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348–57.PubMed Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348–57.PubMed
3.
go back to reference Szabo SJ, Dighe AS, Gubler U, Murphy KM. Regulation of the interleukin (IL)-12Rβ-2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med. 1997;185:817–24.CrossRef Szabo SJ, Dighe AS, Gubler U, Murphy KM. Regulation of the interleukin (IL)-12Rβ-2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med. 1997;185:817–24.CrossRef
4.
go back to reference Goenka S, Kaplan MH. Transcriptional regulation by STAT6. Immunol Res. 2011;50:87–96.CrossRef Goenka S, Kaplan MH. Transcriptional regulation by STAT6. Immunol Res. 2011;50:87–96.CrossRef
5.
go back to reference Yu CWYL, Lee SF. CREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal. Mol Cell Biol. 2001;21:4636–46.CrossRef Yu CWYL, Lee SF. CREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal. Mol Cell Biol. 2001;21:4636–46.CrossRef
6.
go back to reference Wen AY, Sakamoto KM, Miller LS. The role of the transcription factor CREB in immune function. J Immunol. 2010;185:6413–9.CrossRef Wen AY, Sakamoto KM, Miller LS. The role of the transcription factor CREB in immune function. J Immunol. 2010;185:6413–9.CrossRef
7.
go back to reference Kim J, Uyemura K, Van Dyke MK, Legaspi AJ, Rea TH, Shuai K, Modlin RL. A role for IL-12 receptor expression and signal transduction in host defense in leprosy. J Immunol. 2001;167:779–86.CrossRef Kim J, Uyemura K, Van Dyke MK, Legaspi AJ, Rea TH, Shuai K, Modlin RL. A role for IL-12 receptor expression and signal transduction in host defense in leprosy. J Immunol. 2001;167:779–86.CrossRef
8.
go back to reference Liu Y, Guo YL, Zhou SJ, Liu F, Du FJ, Zheng XJ, Jia HY, Zhang ZD. CREB is a positive transcriptional regulator of gamma interferon in latent but not active tuberculosis infections. Clin Vaccine Immunol. 2010;17:1377–80.CrossRef Liu Y, Guo YL, Zhou SJ, Liu F, Du FJ, Zheng XJ, Jia HY, Zhang ZD. CREB is a positive transcriptional regulator of gamma interferon in latent but not active tuberculosis infections. Clin Vaccine Immunol. 2010;17:1377–80.CrossRef
9.
go back to reference Ridley DS, Jopling WH. Classification of leprosy according to immunity. Int J Lepr Other Mycobact Dis. 1966;34:255–73.PubMed Ridley DS, Jopling WH. Classification of leprosy according to immunity. Int J Lepr Other Mycobact Dis. 1966;34:255–73.PubMed
10.
go back to reference Dagur PK, Sharma P, Kumar G, Khan NA, Katoch VM, Sengupta U, Joshi B. Mycobacterial antigen(s) induce anergy by altering TCR- and TCR/CD28- induced signalling events: insights into T-cell unresponsiveness in leprosy. Mol Immunol. 2009;47:943–52.CrossRef Dagur PK, Sharma P, Kumar G, Khan NA, Katoch VM, Sengupta U, Joshi B. Mycobacterial antigen(s) induce anergy by altering TCR- and TCR/CD28- induced signalling events: insights into T-cell unresponsiveness in leprosy. Mol Immunol. 2009;47:943–52.CrossRef
11.
go back to reference Misra N, Murtaza A, Walker B, Narayan PS, Misra RS, Armes V, Singh S, Colston J, Nath I. Cytokine profile of circulating T cells of leprosy patients reflect both indiscriminate and polarized T-helper phenotype is stable and influenced by related antigens of Mycobacterium leprae. Immunology. 1995;86:97–103.PubMedPubMedCentral Misra N, Murtaza A, Walker B, Narayan PS, Misra RS, Armes V, Singh S, Colston J, Nath I. Cytokine profile of circulating T cells of leprosy patients reflect both indiscriminate and polarized T-helper phenotype is stable and influenced by related antigens of Mycobacterium leprae. Immunology. 1995;86:97–103.PubMedPubMedCentral
12.
go back to reference Dockrell HM, Young SK, Britton K, Brennan PJ, Rivoire B, Waters MF, Lucas SB, Shahid F, Dojki M, Chiang TJ, Ehsan Q, McAdam KP, Hussain R. Induction of Th1 cytokine responses by mycobacterial antigens in leprosy. Infect Immun. 1996;64:4385–9.PubMedPubMedCentral Dockrell HM, Young SK, Britton K, Brennan PJ, Rivoire B, Waters MF, Lucas SB, Shahid F, Dojki M, Chiang TJ, Ehsan Q, McAdam KP, Hussain R. Induction of Th1 cytokine responses by mycobacterial antigens in leprosy. Infect Immun. 1996;64:4385–9.PubMedPubMedCentral
13.
go back to reference Weir RE, Brennan PJ, Butlin CR, Dockrell HM. Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects. Clin Exp Immunol. 1999;116:263–9.CrossRef Weir RE, Brennan PJ, Butlin CR, Dockrell HM. Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects. Clin Exp Immunol. 1999;116:263–9.CrossRef
14.
go back to reference Dagur PK, Sharma B, Upadhyay R, Dua B, Rizvi A, Khan NA, Katoch VM, Sengupta U, Joshi B. Phenolic-glycolipid-1 and lipoarabinomannan preferentially modulate TCR- and CD28-triggered proximal biochemical events, leading to T-cell unresponsiveness in mycobacterial diseases. Lipids Health Dis. 2012;11:119–29.CrossRef Dagur PK, Sharma B, Upadhyay R, Dua B, Rizvi A, Khan NA, Katoch VM, Sengupta U, Joshi B. Phenolic-glycolipid-1 and lipoarabinomannan preferentially modulate TCR- and CD28-triggered proximal biochemical events, leading to T-cell unresponsiveness in mycobacterial diseases. Lipids Health Dis. 2012;11:119–29.CrossRef
15.
go back to reference de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174:1209–20.CrossRef de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174:1209–20.CrossRef
16.
go back to reference Schandene L, Alonso-Vega C, Willems F, Gerard C, Delvaux A, Velu T, Devos R, de Boer M, Goldman M. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol. 1994;152:4368–74.PubMed Schandene L, Alonso-Vega C, Willems F, Gerard C, Delvaux A, Velu T, Devos R, de Boer M, Goldman M. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol. 1994;152:4368–74.PubMed
17.
go back to reference Bleharski JR, Li H, Meinken C, Graeber TG, Ochoa MT, Yamamura M, Burdick A, Sarno EN, Wagner M, Rollinghoff M, et al. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science. 2003;301:1527–30.CrossRef Bleharski JR, Li H, Meinken C, Graeber TG, Ochoa MT, Yamamura M, Burdick A, Sarno EN, Wagner M, Rollinghoff M, et al. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science. 2003;301:1527–30.CrossRef
18.
go back to reference Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8:958–69.CrossRef Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8:958–69.CrossRef
19.
go back to reference Sieling PA, Abrams JS, Yamamura M, Salgame P, Bloom BR, Rea TH, Modlin RL. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol. 1993;150:5501–10.PubMed Sieling PA, Abrams JS, Yamamura M, Salgame P, Bloom BR, Rea TH, Modlin RL. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol. 1993;150:5501–10.PubMed
20.
go back to reference Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, Berezovskaya A, Rousset D, Reynes JM, Goldfeld AE. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest. 2000;105:1317–25.CrossRef Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, Berezovskaya A, Rousset D, Reynes JM, Goldfeld AE. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest. 2000;105:1317–25.CrossRef
21.
go back to reference Kaplan MH, Sun YL, Hoey T, Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 1996;382:174–7.CrossRef Kaplan MH, Sun YL, Hoey T, Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 1996;382:174–7.CrossRef
22.
go back to reference Djuretic IM, Levanon D, Negreanu V, Groner Y, Rao A, Ansel KM. Transcription factors T-bet and Runx3 cooperate to activate IFN-γ and silence IL-4 in T helper type 1 cells. Nat Immunol. 2007;8:145–53.CrossRef Djuretic IM, Levanon D, Negreanu V, Groner Y, Rao A, Ansel KM. Transcription factors T-bet and Runx3 cooperate to activate IFN-γ and silence IL-4 in T helper type 1 cells. Nat Immunol. 2007;8:145–53.CrossRef
23.
go back to reference Watford WT, Hissong BD, Durant LR, Yamane H, Muul LM, Kanno Y, Tato CM, Ramos HL, Berger AE, Mielke L, Pesu M, Solomon B, Frucht DM, Paul WE, Sher A, Jankovic D, Tsichlis PN, O'Shea JJ. Tpl2 kinase regulates T cell interferon-gamma production and host resistance to toxoplasma gondii. J Exp Med. 2008;205:2803–12.CrossRef Watford WT, Hissong BD, Durant LR, Yamane H, Muul LM, Kanno Y, Tato CM, Ramos HL, Berger AE, Mielke L, Pesu M, Solomon B, Frucht DM, Paul WE, Sher A, Jankovic D, Tsichlis PN, O'Shea JJ. Tpl2 kinase regulates T cell interferon-gamma production and host resistance to toxoplasma gondii. J Exp Med. 2008;205:2803–12.CrossRef
24.
go back to reference Joshi B, Kedouchi S, Dagur PK, et al. On cell signalling mechanism of Mycobacterium leprae soluble antigen (MLSA) in Jurkat T cells. Mol Cell Biochem. 2006;287:157–64.CrossRef Joshi B, Kedouchi S, Dagur PK, et al. On cell signalling mechanism of Mycobacterium leprae soluble antigen (MLSA) in Jurkat T cells. Mol Cell Biochem. 2006;287:157–64.CrossRef
25.
go back to reference Scheinman EJ, Avni O. Transcriptional regulation of GATA3 in T helper cells by the integrated activities of transcription factors downstream of the interleukin-4 receptor and T cell receptor. J Biol Chem. 2009;284:3037–48.CrossRef Scheinman EJ, Avni O. Transcriptional regulation of GATA3 in T helper cells by the integrated activities of transcription factors downstream of the interleukin-4 receptor and T cell receptor. J Biol Chem. 2009;284:3037–48.CrossRef
26.
go back to reference Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC, Murphy KM. Inhibition of th1 development mediated by GATA-3 through an il-4-independent mechanism. Immunity. 1998;9:745–55.CrossRef Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC, Murphy KM. Inhibition of th1 development mediated by GATA-3 through an il-4-independent mechanism. Immunity. 1998;9:745–55.CrossRef
27.
go back to reference Usui T, Nishikomori R, Kitani A, Strober W. GATA-3 suppress Th1 development by down regulation of STAT4 and not through effects on IL-12Rβ2 chain or T-bet. Immunity. 2003;18:415–28.CrossRef Usui T, Nishikomori R, Kitani A, Strober W. GATA-3 suppress Th1 development by down regulation of STAT4 and not through effects on IL-12Rβ2 chain or T-bet. Immunity. 2003;18:415–28.CrossRef
28.
go back to reference Chang S, Aune TM. Dynamic changes in histone-methylation ‘marks’ across the locus encoding interferon-gamma during the differentiation of T helper type 2 cells. Nat Immunol. 2007;8:723–31.CrossRef Chang S, Aune TM. Dynamic changes in histone-methylation ‘marks’ across the locus encoding interferon-gamma during the differentiation of T helper type 2 cells. Nat Immunol. 2007;8:723–31.CrossRef
29.
go back to reference Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001;2:599–09.CrossRef Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001;2:599–09.CrossRef
30.
go back to reference Penix A, Gupta S, Gollob KJ, Garfein E, Coffman RL, Schindler C, Rothman P. Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. Science. 1995;269:245–7.CrossRef Penix A, Gupta S, Gollob KJ, Garfein E, Coffman RL, Schindler C, Rothman P. Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. Science. 1995;269:245–7.CrossRef
31.
go back to reference Zhang F, Wang DZ, Boothby M, Penix L, Flavell RA, Aune TM. Regulation of the activity of IFN-gamma promoter elements during Th cell differentiation. J Immunol. 1998;161:6105–12.PubMed Zhang F, Wang DZ, Boothby M, Penix L, Flavell RA, Aune TM. Regulation of the activity of IFN-gamma promoter elements during Th cell differentiation. J Immunol. 1998;161:6105–12.PubMed
32.
go back to reference Samten B, Howard ST, Weis SE, Wu S, Shams H, Townsend JT, Safi H, Barnes PF. Cyclic AMP response element-binding protein positively regulates production of IFN-γ by T cells in response to a microbial pathogen. J Immunol. 2005;174:6357–63.CrossRef Samten B, Howard ST, Weis SE, Wu S, Shams H, Townsend JT, Safi H, Barnes PF. Cyclic AMP response element-binding protein positively regulates production of IFN-γ by T cells in response to a microbial pathogen. J Immunol. 2005;174:6357–63.CrossRef
Metadata
Title
Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens
Authors
Rajni Upadhyay
Bhavyata Dua
Bhawna Sharma
Mohan Natrajan
Ajai Kumar Jain
Balaji Kithiganahalli Narayanaswamy
Beenu Joshi
Publication date
01-12-2019
Publisher
BioMed Central
Keywords
Cytokines
Leprosy
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3601-z

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.